Lenz Robert A.

Track

Insider profile

Lenz Robert A.'s trades of Neumora Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-02-20 2025-02-18
PlS Planned sale
51,219 +7.6%
93.27
US$1,421,053 		51,219 +7.6% 93.27 US$1,421,053
2025-02-18 2025-02-18
PrS Proposed sale
95,131
490.92
US$4,564,183 		95,131 490.92 US$4,564,183
2024-10-11 2024-10-10
PlS Planned sale
46,571 +21.4%
100.41
US$3,231,881 		46,571 +21.4% 100.41 US$3,231,881
2024-10-10 2024-10-10
PrS Proposed sale
8,260
15.09
US$124,603 		8,260 15.09 US$124,603
2024-10-11 2024-10-09
PlS Planned sale
5,563 -1.7%
15.01
US$83,507 		5,563 -1.7% 15.01 US$83,507
2024-10-09 2024-10-09
PrS Proposed sale
5,563
15.01
US$83,507 		5,563 15.01 US$83,507
2024-09-19 2024-09-18
PlS Planned sale
10,676 -3.1%
12.09
US$129,091 		10,676 -3.1% 12.09 US$129,091
2024-09-18 2024-09-18
PrS Proposed sale
10,676
12.09
US$129,091 		10,676 12.09 US$129,091
2024-09-19 2024-09-17
PlS Planned sale
30,788 -8.3%
11.81
US$363,736 		30,788 -8.3% 11.81 US$363,736
2024-09-17 2024-09-17
PrS Proposed sale
30,788
11.81
US$363,734 		30,788 11.81 US$363,734
2024-09-16 2024-09-12
PlS Planned sale
32,948 -8.2%
11.43
US$376,665 		32,948 -8.2% 11.43 US$376,665
2024-09-12 2024-09-12
PrS Proposed sale
32,948
11.43
US$376,665 		32,948 11.43 US$376,665